Bharat Biotech’s rotavirus oral vaccine, Rotavac, has been introduced by Nigeria to immunise children against diarrhoeal disease.
The life-threatening Rotavirus infection, which affects millions of children worldwide, is the cause for death of about 50,000 children under the age of five - each year in Nigeria, the Hyderabad-based vaccine maker said on Wednesday.
“We are committed to supporting and reducing the infectious disease burden amongst children in developing world and to ensure nations like Nigeria in the African continent have access to cost-effective world-class interventions for infants and vulnerable populations. Rotavac is safe and effective at preventing diarrhoeal disease caused by the Rotavirus,” Chairman and Managing Director Krishna Ella said.
